Alliance Research Institute | Bell Gardens, CA

Research site
7218 Garfield Avenue, Bell Gardens, California, United States of America
Site insights

Top conditions

Irritable Bowel Syndrome (2 trials)

Constipation (2 trials)

Syndrome (2 trials)

Weight Loss (1 trial)

Top treatments

Belviq XR®

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) (LINZESS)

The objective of LIN-MD-64 is to evaluate the safety and efficacy of 12 weeks of linaclotide therapy (72 μg daily) in comparison with placebo in pedi...

Active, not recruiting
Functional Constipation
Irritable Bowel Syndrome With Constipation
Drug: Placebo (FC Participants)
Drug: Linaclotide 145 μg (IBS-C Participants)

LIN-MD-66 is a Phase 3 open-label study with 24 weeks (Functional Constipation participants) or 52 weeks (Irritable bowel syndrome with constipation...

Functional Constipation
Irritable Bowel Syndrome With Constipation
Drug: Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 completers)
Drug: Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers)

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

Active, not recruiting
Drug: MR-100A-01

Trial sponsors

AbbVie logo

AbbVie (2 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems